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ABSTRACT:  
This case report describes a dermatologic finding that is not typical in the adult population, but may be 
medically significant.  A 39-year-old female patient with a past medical history that was negative for 
autoimmune disorders, vasculitides, or chronic infectious disease presented to our emergency department 
for evaluation of a painful rash on the bilateral lower extremities. She complained of two days of worsening 
raised, erythematous, pruritic and painful patches around both ankles, some of which had opened to become 
weeping sores. There was surrounding edema of both extremities. She denied any systemic symptoms. 
Online literature, primarily UpToDate was reviewed, and it was suspected that her rash may have been 
Henoch-Schönlein Purpura (HSP), given her lack of other medical history and a visual appearance that 
seemed consistent with the condition. To evaluate for renal involvement and systemic inflammation, labs 
were drawn and were grossly unremarkable except for a mild elevation in her C-reactive protein with a level 
of 37.6 mg/L. She was treated with intravenous (IV) hydration and IV ketorolac, with resultant symptomatic 
improvement. Since she did not have any apparent systemic involvement, she was discharged to follow up 
with rheumatology, with a recommendation to take over the counter non-steroidal anti-inflammatory drugs 
(NSAIDs). The patient was ultimately seen by rheumatology several months later, and a biopsy of the lesions 
demonstrated what appeared to be Henoch-Schönlein Purpura given her clinical presentation. Henoch-
Schönlein Purpura can occur in adults, however rare, requiring close follow-up since in the adult population, 
it may result in renal failure and need for dialysis. 
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Introduction: 
Patients frequently present to the emergency department (ED) 
with rashes of varying etiology, pathology, and significance.  
Frequently they are benign in nature, and respond to 
symptomatic treatment and self-resolve with time. However, a 
minority of dermatologic conditions that are seen in the ED 
carry medical significance and should not be missed. This adult 
patient presented with a rash that was suspicious for Henoch-
Schönlein Purpura. This condition is rare in the adult population 
with an incidence of 3.4-14.3 cases per million,1 but carries a 
risk of serious renal sequelae. Studies reveal significant 
incidence of serious sequelae, such as renal involvement in 60% 
of adult patients, with 28% of them progressing to chronic renal 
disease.2  A second retrospective study by Harzallah et al, 
identified renal failure in 44% of patients, with 36% of those 
going on to develop chronic kidney disease, and an overall renal 
survival of 57% at 5 years.3 Thus, adult patients with suspected 
Henoch-Schönlein Purpura are at significant risk of life-altering 
renal injury, and so should always be referred to close specialist 
follow up. The rarity of Henoch-Schönlein Purpura makes this 
case unique, since an adult presentation is so infrequently seen.  
 
History of present illness: 
A 39-year-old female with  a past medical history that was 
negative for autoimmune disorders, vasculitides, or chronic 
infectious disease, and a family history that was negative for 
autoimmune disease, vasculitides or connective tissue disorders 
presented to the emergency department with a two-day history 
of worsening bilateral ankle swelling, and a red patchy rash 
which was pruritic and painful. She was concerned that the rash 
was related to insect bites.  Several of the patches had opened 
to reveal oozing sores since their appearance. She denied 
generalized illness, fevers, chills, abdominal pain, nausea, 
vomiting, or diarrhea. She denied recent gastrointestinal illness, 
gastrointestinal bleeding, recent upper respiratory infection, 
visual changes, or recent unintentional weight loss. She denies 
any jaundice, any other rashes, drug use, high risk sexual 
exposure, or any travel outside of the country or the state. 
 
Significant findings: 
The images show a raised, palpable, purpuric rash on the lower 
extremities, surrounded by a mild, 1+ non-pitting edema. 
Several of the lesions are exfoliated with serous discharge. 
There is no surrounding erythema, fluctuance, or lymphangitis 
to suggest cellulitis.  There was no tenderness to palpation; 
however, pruritus was exacerbated on palpation. 
 
Patient course: 
The patient’s lesions were evaluated by several physicians in 
the ED. After review of UpToDate and literature available on the 
internet, the lesions were suspected to be typical of Henoch-
Schönlein Purpura. Infectious causes or dermatitis were 
considered, but there were no physical examination findings to 
suggest cellulitis, and the patient did not report any new 
potential irritants, making this less likely. She did report 
suspected outdoor insect bites. However, the symmetrical and 
evenly distributed purpura make this an unlikely diagnosis. Drug 
induced vasculitis was considered; however, she denied any 
illicit drug use on this encounter, and was not on any 
medications. Systemic infectious conditions were considered, 
including human immunodeficiency virus and hepatitis as a 
cause of vasculitic lesions. However, she denied any preceding 
systemic symptoms with a pan-negative review of systems, and 
did not have any social or medical history to suggest a high risk 
for such conditions, having denied any history of drug use, high 
risk sexual contacts, or blood product exposures. Autoimmune 
conditions were considered; however, she had no systemic 
symptoms and no personal or family history of autoimmune 
disorders or atopy.  
 
Laboratory studies were obtained, including a complete blood 
count, comprehensive metabolic panel, C-reactive protein 
(CRP), erythrocyte sedimentation rate (ESR), and a urinalysis. All 
were normal except for a mild elevation of CRP to 37.6 mg/L 
with a normal ESR at 22.  She was treated with 15mg of IV 
ketorolac and 1 liter of IV normal saline for her discomfort and 
for renal protection, which resulted in symptomatic 
improvement. Guidelines as published in UpToDate, which was 
immediately available at the time of this encounter, were 
reviewed, since this condition is not commonly seen in adults, 
and it was determined that non-steroidal anti-inflammatory 
drugs for symptomatic treatment were indicated, and that 
steroids have not been shown to have any effect on long term 
gastrointestinal or renal outcome. She was subsequently 
discharged to home with outpatient follow-up with 
rheumatology.  
 
Chart review of the period subsequent to her discharge 
revealed that one month after initial treatment, she was 
admitted for treatment of cellulitis of the affected wounds. 
During this admission, Henoch-Schönlein Purpura was 
mentioned as a differential diagnosis, but was not confirmed, 
and she was discharged after clinical improvement. She was 
seen several times by wound care since then. The following 
year, seven months after the initial admission, she was finally 
evaluated by the rheumatologist as referred, with the note 
citing insurance difficulties as a primary barrier to her lack of 
follow up. The rheumatologist  noted that she had continued 
relapsing and remitting palpable, purpuric lesions of the same 
description, and considered nonspecific vasculitides, Henoch-
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Schönlein Purpura, autoimmune complex diseases, and chronic 
infectious disease such as human immunodeficiency virus, 
syphilis, and hepatitis as potential causes of her findings, and 
referred her for further testing including but not limited to anti-
nuclear antibody, rheumatoid factor, and viral testing, which 
have not been performed at the time of the most recent chart 
review for this case. A biopsy, however, was recently performed 
and the histologic interpretation states “Confluent epidermal 
necrosis with underlying vasculitis. Considering the clinical 
information provided, this can represent a manifestation of 
Henoch-Schönlein Purpura.” 
 
Discussion: 
This case report serves as an example of a dermatologic finding 
that is exceedingly rare in adults, but may carry significant 
medical sequelae and requires close follow-up. Henoch-
Schönlein Purpura most often presents in young children, and is 
an IgA immune-mediated vasculitis that results in abdominal 
pain, joint pain, and possible acute kidney injury.  In young 
children, it is typically a self-limiting condition that results in 
moderate abdominal pain and the pathognomonic rash, which 
is typically palpable and raised, with variable degrees of skin 
breakdown, and generally distributed among the lower 
extremities.  The rash may be associated with edema; however, 
it should be noted that edema is typically dependent, and in 
non-ambulatory patients such as young infants, it will be 
present on their backs. Severe pain may be due to intestinal 
involvement with purpura and may lead to intussusception by 
means of a mechanical lead point.  In some cases, such as a 
case report by Lerkvaleekul et al, of a 4-year-old boy, intestinal 
involvement may progress to severe intestinal injury and 
perforation.4 Renal manifestations of HSP are less common in 
children; however, evaluation of renal function and follow-up is 
still warranted.   
 
Gastrointestinal symptoms are not limited to children, albeit 
are less frequent in adults. Gastrointestinal involvement in 
adults may be severe and may require surgical management.5,6 
In at least one case, in an older patient at 63 years of age, it 
resulted in death due to extensive bowel necrosis and 
hemorrhage as well as renal failure.7 In adults, GI 
manifestations are less frequent, and HSP more frequently 
results in development of arthritis or renal failure, in certain 
extreme cases requiring dialysis.1,2,3 Follow-up of kidney 
function is critical in adults.   
 
Standard therapy in children typically consists of NSAIDs, with 
steroids having a questionable role in the management of this 
condition. Steroids have been shown to improve abdominal 
pain in children; however, no statistically significant effect on 
renal outcomes has been shown,8,9 and a 6 month review of 
223 patients revealed that although steroids result in 
symptomatic improvement of abdominal pain in affected 
children, they do not alter the clinical course.10,11  A case report 
and literature review by Kurnia et al, confirms the utility of 
steroids as symptomatic therapy, without any long term benefit 
in terms of gastrointestinal or renal sequelae in children.12 In 
persistent cases, immunomodulators have been shown to be 
effective in children in chronic recurrent HSP, resulting in 
reduced hospitalization and improved symptoms.13  There is a 
small amount of literature regarding HSP in adults, mostly 
limited to case reports, and no strict guideline for therapy 
exists. Identification of HSP in the adult patient may also be 
difficult, given the higher likelihood of other forms of vasculitis 
and other infectious conditions, such as viral illnesses that are 
less common in childhood including HIV and viral hepatitis.  The 
American College of Rheumatology 1990 guideline for 
identification of HSP appears to be sensitive and specific in the 
identification of this condition in children; however, given that 
one of the inclusion criteria is an age of less than 20 and 
presence of abdominal pain, which is less common in adults, it 
is less relevant in the adult patient.14 
 
The main finding of this case report is the classic appearance of 
these lesions and their distribution in an adult, and the 
management and follow-up that was undertaken given these 
findings.  The rash is classically purpuric, palpable, raised, and 
typically distributed in the lower extremities in the adult as it is 
in the child. Other vasculitides may result in palpable lesions, 
which may be similar to those found in this IgA vasculitis, but 
typically associated with systemic symptoms. It may be 
confused with urticarial lesions; however HSP lesions will 
typically be isolated to the lower extremities rather than 
diffuse, but will appear over a greater period of time and are 
associated with a greater degree of skin breakdown. Henoch-
Schönlein Purpura in the adult may result in life-altering renal 
sequelae, even in the absence of abdominal pain, and a high 
index of suspicion for this condition should be maintained. The 
primary take-away point is that amongst numerous rashes, this 
one may be unexpected in an adult, should not be missed, and 
requires close follow-up to ensure that renal failure does not 
result as a complication of this condition. 
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